This popular heart failure drug is no better than older ones
In a new study from Washington University in St. Louis, researchers found that a widely used heart failure drug named sacubitril/valsartan is no better...
How to protect your eyes from diabetes
Diabetic retinopathy affects nearly 8 million Americans, and that number is expected to double by 2050.
But knowing the risks and symptoms and seeking an...
Over-the-counter pain relievers may harm your blood pressure
In a new study from the American Heart Association, researchers found while nearly half of U.S. adults have high blood pressure (HBP), only 29%...
This gout drug could help treat COVID-19
As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2.
In a...
This COVID vaccine is more effective against Delta
In a recent study published in Morbidity and Mortality Weekly Report, researchers found COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the...
PTSD, anxiety, loneliness are common after COVID-19 hospitalization
COVID-19 wreaks havoc on the body from the lungs and heart to the kidneys and liver.
But those that survive hospitalization from the contagion often...
1 in 20 people can achieve type 2 diabetes remission
In a new study from the University of Edinburgh, researchers found around one in twenty people in Scotland diagnosed with type 2 diabetes achieve...
Doing this thing is the key to survive a stroke
In a recent study published in Stroke, researchers emphasize how critical it is for survivors of first-time stroke to take medications on an ongoing basis,...
Exercise may help you overcome alcohol cravings
In a new study from Loughborough University, researchers found exercise can strongly reduce alcohol cravings.
They examined 60 male and female participants in universities, aged 18...
How to treat and manage Alzheimer’s disease
Alzheimer's disease and the urgent need for more effective treatments have been making headlines this year, with the FDA approving limited use of a...